Sg Americas Securities, LLC Lexicon Pharmaceuticals, Inc. Transaction History

Sg Americas Securities, LLC

$24.1 Billion
Q2 2025

A detailed history of Sg Americas Securities, LLC transactions in Lexicon Pharmaceuticals, Inc. stock. As of the latest transaction made, Sg Americas Securities, LLC holds 13,814 shares of LXRX stock, worth $14,642. This represents 0.0% of its overall portfolio holdings.

Number of Shares

13,814

Previous 68,012 79.69%

Holding current value

$14,642

Previous $31,000 58.06%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 08, 2025	SELL	$0.42 - $0.95 $22,763 - $51,488	-54,198 Reduced 79.69%	13,814 $13,000
Q1 2025 Apr 15, 2025	BUY	$0.29 - $0.96 $3,684 - $12,195	12,704 Added 22.97%	68,012 $31,000
Q4 2024 Jan 17, 2025	BUY	$0.65 - $2.08 $5,991 - $19,173	9,218 Added 20.0%	55,308 $41,000
Q3 2024 Oct 03, 2024	BUY	$1.51 - $2.39 $36,078 - $57,104	23,893 Added 107.64%	46,090 $72,000
Q2 2024 Jul 12, 2024	BUY	$1.54 - $2.28 $4,509 - $6,675	2,928 Added 15.2%	22,197 $37,000
Q1 2024 May 06, 2024	SELL	$1.3 - $3.58 $31,881 - $87,795	-24,524 Reduced 56.0%	19,269 $46,000
Q4 2023 Jan 12, 2024	SELL	$1.0 - $1.53 $14,914 - $22,818	-14,914 Reduced 25.4%	43,793 $67,000
Q3 2023 Oct 13, 2023	BUY	$1.06 - $2.33 $62,229 - $136,787	58,707 New	58,707 $64,000
Q1 2023 Apr 28, 2023	BUY	$1.99 - $2.68 $25,145 - $33,864	12,636 Added 50.44%	37,689 $92,000
Q4 2022 Feb 02, 2023	SELL	$1.8 - $2.56 $17,164 - $24,412	-9,536 Reduced 27.57%	25,053 $48,000
Q3 2022 Oct 31, 2022	SELL	$1.94 - $3.43 $1,703 - $3,011	-878 Reduced 2.48%	34,589 $83,000
Q2 2022 Jul 29, 2022	BUY	$1.31 - $2.69 $2,288 - $4,699	1,747 Added 5.18%	35,467 $66,000
Q1 2022 Apr 29, 2022	BUY	$1.95 - $3.89 $27,058 - $53,977	13,876 Added 69.93%	33,720 $70,000
Q4 2021 Feb 07, 2022	SELL	$3.81 - $6.16 $152,963 - $247,311	-40,148 Reduced 66.92%	19,844 $78,000
Q3 2021 Nov 01, 2021	SELL	$3.38 - $5.35 $80,988 - $128,191	-23,961 Reduced 28.54%	59,992 $289,000
Q2 2021 Aug 12, 2021	BUY	$4.12 - $5.87 $345,886 - $492,804	83,953 New	83,953 $385,000
Q1 2021 May 13, 2021	SELL	$3.45 - $9.09 $68,261 - $179,854	-19,786 Closed	0 $0
Q4 2020 Feb 04, 2021	BUY	$1.05 - $3.67 $20,775 - $72,614	19,786 New	19,786 $68,000
Q3 2020 Nov 09, 2020	SELL	$1.44 - $2.1 $32,052 - $46,743	-22,259 Closed	0 $0
Q2 2020 Jul 20, 2020	BUY	$1.75 - $2.3 $10,092 - $13,264	5,767 Added 34.97%	22,259 $44,000
Q1 2020 Apr 30, 2020	BUY	$1.8 - $4.28 $29,685 - $70,585	16,492 New	16,492 $32,000
Q4 2017 Jan 24, 2018	SELL	$8.77 - $12.28 $147,151 - $206,046	-16,779 Closed	0 $0
Q3 2017 Nov 07, 2017	BUY	$12.17 - $16.3 $204,200 - $273,497	16,779	16,779 $206,000

Others Institutions Holding LXRX

# of Institutions

130

Shares Held

226M

Call Options Held

436K

Put Options Held

138K

View Full List

About LEXICON PHARMACEUTICALS, INC.

Ticker LXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,726,000
Market Cap $200M
Description
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...

More about LXRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.

Account

Sg Americas Securities, LLC Lexicon Pharmaceuticals, Inc. Transaction History